Glaxo to pay $750m over adulterated drug claims

The drug company GlaxoSmithKline PLC will pay $750m (€542m) to settle allegations that it knowingly manufactured and sold adulterated drugs, federal prosecutors in the US said yesterday.

Glaxo to pay $750m over adulterated drug claims

The drug company GlaxoSmithKline PLC will pay $750m (€542m) to settle allegations that it knowingly manufactured and sold adulterated drugs, federal prosecutors in the US said yesterday.

US Attorney Carmen Ortiz said the London-based company will pay $150m in criminal fines and $600m in civil penalties related to faulty manufacturing processes at its plant in Cidra, Puerto Rico.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited